Post-COVID-19 non-traumatic iliopsoas hematoma: A case report

BACKGROUND: Critically ill COVID-19 patients have an elevated risk of experiencing hypercoagulable conditions. Currently, many COVID-19 patients have been administered anticoagulation or antiplatelet therapies to lower the risk of systematic thrombosis. Iliopsoas hematoma is a potentially fatal and...

Descripción completa

Detalles Bibliográficos
Autores principales: Al jumaan, Mohammed A., Alahmari, Nawaf, Elnour, Ahmed, Alshahrani, Saad, Mattoo, Arif, Alghamdi, Mohannad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293483/
https://www.ncbi.nlm.nih.gov/pubmed/35875171
http://dx.doi.org/10.1016/j.jtumed.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293483/
https://www.ncbi.nlm.nih.gov/pubmed/35875171
http://dx.doi.org/10.1016/j.jtumed.2022.07.001

Ejemplares similares